Many Cancer Drugs Don’t Extend Life cover art

Many Cancer Drugs Don’t Extend Life

Many Cancer Drugs Don’t Extend Life

Listen for free

View show details

About this listen

Treating cancer is a massive business. In 2024 alone, cancer treatments generated at least $200 billion in worldwide sales for the pharmaceutical industry, more than the obesity drug rush. But a Bloomberg News analysis showed that fewer than half of treatments reviewed — some of which have painful side effects — have been shown to extend patients’ lives.

On today’s Big Take podcast, Bloomberg senior healthcare reporter Robert Langreth takes host David Gura inside what some doctors call the “cancer-industrial complex” — from the regulatory landscape that ushered in a wave of lucrative new drugs to the damaging financial and health impacts some treatments can have on patients.

Read more:

Cancer Drugs Cost More Than Ever. They Often Don’t Extend Lives.

The Implants Were Supposed to Dissolve. They Didn’t.

Pharma Is Pushing $200,000 Cancer Drugs When Cheaper Doses May Work

Cancer Doctors Are Making a Fortune Off Drug-Trial Participants

One Generic Cancer Drug Costs $35. Or $134. Or $13,000.

See omnystudio.com/listener for privacy information.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.